Mangrove Partners Bio Rad Laboratories, Inc. Transaction History
Mangrove Partners
- $778 Million
- Q3 2025
A detailed history of Mangrove Partners transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Mangrove Partners holds 126,853 shares of BIO stock, worth $39.7 Million. This represents 4.57% of its overall portfolio holdings.
Number of Shares
126,853Holding current value
$39.7 Million% of portfolio
4.57%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
435Shares Held
19.4MCall Options Held
6KPut Options Held
3.3K-
First Eagle Investment Management, LLC2.52MShares$789 Million1.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.79MShares$562 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$486 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.06MShares$333 Million0.07% of portfolio
-
Veritas Asset Management LLP844KShares$264 Million2.74% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.71B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...